Mark Moore

Mark Moore

Company: GemPharmatech

Job title: CEO

Seminars:

Humanised Models for Pre-Clinical Antibody Development 9:10 am

Immunodeficient mice for immune system engraftment Genetic modifications for humanised antibody targets Bi-specific antibody developmentRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.